A systematic review of intravitreal bevacizumab for the treatment of diabetic macular edema
Diabetic retinopathy (DR) and diabetic macular edema (DME) are microvascular complications of diabetes that are a leading cause of blindness in the diabetic population. DME -- which is swelling of the retina due to leakage of fluid from blood vessels within the macula, the central portion of the ret...
Main Authors: | , , |
---|---|
Corporate Author: | |
Format: | eBook |
Language: | English |
Published: |
Ottawa, Ontario
Canadian Agency for Drugs and Technologies in Health
May 2012, 2012
|
Series: | Rapid response report : peer-reviewed summary with critical appraisal
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references